Kerry R Benson

Title: Kerry R. Benson: Pioneering Innovations in Pharmaceutical Compositions

Introduction: Kerry R. Benson, an accomplished inventor based in Morgantown, West Virginia, has made significant contributions to the field of pharmaceuticals. With a robust portfolio of two patents, Benson continues to push the boundaries of medical innovation, particularly in drug formulation and delivery systems.

Latest Patents: Kerry R. Benson's most notable inventions involve novel pharmaceutical compositions featuring phenytoin sodium. One of her latest patents describes an innovative composition that includes an admixture of phenytoin sodium and an erodible matrix, designed to extend the release of the drug over approximately a two-hour period. This erodible matrix comprises specific binder(s) and diluent(s) that adeptly control the drug's release from the composition. Furthermore, this formulation can include an alkaline pH modifier, enhancing the effectiveness of phenytoin sodium.

Career Highlights: Kerry R. Benson is associated with Mylan Pharmaceuticals Inc., a key player in the pharmaceutical industry. Her role and contributions at Mylan underscore her commitment to developing effective therapeutic solutions that benefit a wide range of patients.

Collaborations: Throughout her career, Benson has worked alongside esteemed colleagues such as William J. Addicks and Joseph P. Duda. Their collaborative efforts have further advanced the research and development of pharmaceutical formulations, contributing to the overall innovation within the field.

Conclusion: As an inventor, Kerry R. Benson exemplifies the spirit of innovation in pharmaceuticals. Her work on phenytoin sodium compositions not only showcases her expertise but also reflects a dedication to improving patient care. Her ongoing contributions promise to impact the pharmaceutical industry positively, paving the way for more efficient drug delivery systems.